Search alternatives:
significantly impair » significantly impairs (Expand Search), significantly impaired (Expand Search), significantly impact (Expand Search)
higher decrease » higher degree (Expand Search), higher degrees (Expand Search), highest increase (Expand Search)
significantly impair » significantly impairs (Expand Search), significantly impaired (Expand Search), significantly impact (Expand Search)
higher decrease » higher degree (Expand Search), higher degrees (Expand Search), highest increase (Expand Search)
-
181
Summary of post-treatment disease course measures from MDMA-AT publications.
Published 2025Subjects: -
182
-
183
Summary of post-treatment CAPS score changes from clinical trials with FDA-approved medications.
Published 2025Subjects: -
184
-
185
-
186
-
187
Summary of post-treatment disease course measures from off-label medications clinical trials.
Published 2025Subjects: -
188
Summary of post-treatment CAPS score changes from clinical trials with psychotherapies.
Published 2025Subjects: -
189
Summary of clinical studies of FDA-approved medications for PTSD: Disease course outcomes.
Published 2025Subjects: -
190
Summary of post-treatment disease course measures from clinical trials with psychotherapies.
Published 2025Subjects: -
191
-
192
-
193
Post-treatment CAPS score changes from clinical trials with off-label PTSD medications.
Published 2025Subjects: -
194
-
195
-
196
-
197
-
198
-
199
-
200
Column charts of WiAUC in therapy and control group at baseline and follow-up.
Published 2025Subjects: